“Genome Editing: The Next Frontier”: 4th Conference in the Bridging Biomedical Worlds Series
The Fondation IPSEN today announced the fourth Bridging Biomedical Worlds Conference, “Genome Editing: The Next Frontier”, which will be focused on the improvement and most recent applications of genome editing tools. This meeting will take place in Singapore from February 5 th to 7 th 2018.
The Significance of Genome Editing
For decades, scientists have searched for a genome editing tool that will facilitate the easy and sustainable modification of genes in health and biomedical research. The engineering of CRISPR-Cas9 five years ago proved to be a breakthrough in the field. CRISPR-Cas9 is a natural defense system in bacteria that has been modified to allow any DNA modification in all living species. CRISPR-Cas9 technology has opened up promising avenues in various scientific fields, and is being utilized in the development of innovative therapies for cancer and other infectious and genetic diseases.
The 2018 Bridging Biomedical Worlds Conference, “Genome Editing: The Next Frontier”, will be held in Singapore from February 5th to 7th 2018. Feature a line-up of internationally renowned speakers who are experts in their fields, the Conference will cover a range of topics including natural bacterial immune mechanisms, the next generation of genome editing tools, and applications of genome editing tools in scientific discovery and in therapy.
This event is jointly organized by Fondation IPSEN, AAAS/Science, AAAS/Science Translational Medicine, and A*STAR’s Institute of Molecular and Cell Biology (IMCB).
Engineering Smarter T-cells
CRISPRs for Attack and Defense
|Avec Dipali SASHITAL, Rotem SOREK, Seokjoong KIM|
Advances in Genome Editing
|Avec Nicole GAUDELLI, Martin JINEK, Farren ISAACS, Gene YEO, Fabrice VANDEPUT|
CRISPRs as a Discovery Tool
|Avec Mashito IKAWA, Neville SANJANA, David BIKARD|
Table ronde : Scientific Challenges for Genome Editing
Therapeutic Applications of Gene Editing
|Avec Suk See DE RAVIN, Paula CANNON, Eric OLSON, Waseem QASIM, Andrea CRISANTI|
Table ronde : Therapeutic Challenges for Genome Editing
Functional Genomics to Study Cancer
This scientific meeting has been recognized “INNOVATION YEAR 2018” by the French Singapore Embassy. This label has been launched in 2017 by Mister François Hollande, former President of the French Republic, and Lee Hsien Loong, Singapore prime minister, to reinforce bilateral initiatives and collaboration in key sectors like health or biotechnology.
Detailed program: https://www.bridgingbiomedicalworlds.com
To RSVP for the Conference, please contact: firstname.lastname@example.org
About the Bridging Biomedical Worlds series
The Fondation IPSEN and the American Association for the Advancement of Science launched a new Conference series in 2014 entitled “Bridging Biomedical Worlds” to facilitate the global exchange of knowledge about important advances in key research areas, and boost communication and cooperation among researchers, clinicians, and industry scientists from East and West. Each year a ground-breaking topic is tackled with a local partner in a different country in Asia.
More info on the previous meetings: https://www.bridgingbiomedicalworlds.com/previous-edition/
About A*STAR’s Institute of Molecular and Cell Biology (IMCB)
The Institute of Molecular and Cell Biology (IMCB) was launched on 23 January 1985, with its official opening ceremony held on 2 October 1987 at the National University of Singapore (NUS). It subsequently became an autonomous research institute (RI) of A*STAR, moving to Biopolis in 2004. IMCB’s vision is to be a premier cell and molecular biology institute which addresses the mechanistic basis of human diseases and its mission is to conduct cutting-edge discovery research in disease pathways; to groom early career researchers to be future leaders in research; and to collaborate with medical and industry communities for research impact. IMCB plays an important role training and recruiting scientific talents, and has contributed to the development of other research entities in Singapore. Its success in fostering a biomedical research culture in Singapore has catalysed Singapore’s transformation into an international hub for biomedical research, development and innovation.
Funded primarily by the Biomedical Research Council (BMRC) of A*STAR, IMCB’s Discovery research comprises 5 major programmes: Cancer Cell Signalling, Multi-Modal Molecular (M3) Biology, Epigenetics and Diseases, iPS cell and Regenerative Medicine, and Technology and Translation. IMCB’s technologies and platforms focus on Genome-wide RNAi, Humanized Mouse Models, Proteomics and Protein Engineering, Gene Therapy and Gene Editing, and Molecular Histopathology.
IMCB strives to maintain the scientific excellence of PI-driven research and at the same time aims to promote collaborative team-based projects of medical and industrial relevance.
For more information about IMCB, visit www.imcb.a-star.edu.sg.
The American Association for the Advancement of Science (AAAS) is the
world’s largest general scientific society and publisher of the journal Science
as well as Science Translational Medicine (www.sciencetranslationalmedicine.org),
Science Signaling (www.sciencesignaling.org),
and Science Advances (http://advances.sciencemag.org/).
AAAS was founded in 1848, and includes some 261 affiliated societies and
academies of science, serving 10 million individuals. Science has
the largest paid circulation of any peer-reviewed general science
journal in the world, with an estimated total readership of 1 million.
The non-profit AAAS (www.aaas.org)
is open to all and fulfills its mission to “advance science and serve
society” not only by publishing the very best scientific research but
also through initiatives in science policy, international programs and
About AAAS/Science Translational Medicine
Science Translational Medicine was launched in October 2009. The
goal of Science Translational Medicine is to promote human health
by providing a forum for communicating the latest biomedical research
findings from basic, translational, and clinical researchers from all
established and emerging disciplines relevant to medicine. Despite 50
years of advances in our fundamental understanding of human biology and
the emergence of powerful new technologies, the translation of this
knowledge into effective new treatments and health measures has been
slow. This paradox illustrates the daunting complexity of the challenges
faced by translational researchers as they apply the basic discoveries
and experimental approaches of modern science to the alleviation of
human suffering. A major goal of Science Translational Medicine is
to publish papers that identify and fill the scientific knowledge gaps
at the junction of basic research and medical application in order to
accelerate the translation of scientific knowledge into new methods for
preventing, diagnosing and treating human disease.
The Fondation IPSEN
Established in 1983 under the aegis of the Fondation de France, the
ambition of the Fondation IPSEN is to initiate a reflection about the
major scientific issues of the forthcoming years. The long-standing
mission of the Fondation IPSEN is to contribute to the development and
dissemination of scientific knowledge by fostering interaction between
scientists and clinicians. It has developed an important international
network of scientific experts who meet regularly at meetings known as Colloques
Médecine et Recherche. Moreover, the Fondation IPSEN has created
several series of meetings in partnership with the Salk Institute, the
Karolinska Institute as well as with the scientific journals Cell
and Science. The Fondation IPSEN produced several hundred
publications and more than 250 scientists have been awarded prizes and
For further information, and to RSVP for the Conference:
Yannick TANGUY, Tel: +33 (0)6 81187860
Twitter: @FondationIpsen (#BridgBioWorlds)
LinkedIn: Fondation IPSEN
YouTube: Fondation IPSEN video
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Global Technology Association ISACA Launching Future-focused Initiatives in Its 50th Anniversary Year23.1.2019 17:22 | Tiedote
Now more than 450,000 engaged professionals and 140,000 members strong, global information technology association ISACA was founded by seven individuals as the EDP Auditing Association in California at the dawn of the information systems era—1969. Serving audit, governance, risk and cybersecurity professionals and their enterprises, today ISACA has a presence in 188 countries. Headquartered near Chicago, Illinois, USA, ISACA also established an entity in Beijing, China, last year, and acquired the CMMI Institute in 2016. In 2019—its 50th anniversary year—ISACA has adopted the theme, “Honoring Our Past. Innovating Our Future.” The organization has multiple initiatives planned to mark this milestone, including: Transforming IT Audit initiative—In February 2019, ISACA will launch a Transforming IT Audit microsite with resources to help IT auditors successfully navigate the future of the profession, including emerging areas like AI and blockchain, and featuring results from ISACA’s new glo
Wipro Ranked Third Fastest Growing Global IT Services Brand in 201923.1.2019 17:18 | Tiedote
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, has been ranked the third fastest growing global IT services brand in 2019 in a study conducted by Brand Finance, the world’s leading brand valuation firm. Wipro is also among the top 10 most valuable brands in the global IT services sector. According to Brand Finance’s IT Services annual report for 2019, which features 15 leading brands in the segment, Wipro has a total brand value of USD 4.002 billion, up 25% on year, emerging as one of the strongest brands in the category with an AA+ Brand rating. Brand Finance, in their official press release noted that Wipro’s significant investments in digital transformation capabilities, niche acquisitions, and a recent brand refresh, have propelled it to the third fastest growing brand in the segment. The report analyses the brand value and brand strength of the 5000 largest brands across 38 sectors in t
Velodyne Lidar and YellowScan Lead Drone Surveying Market for Highway Capacity Expansion23.1.2019 16:00 | Tiedote
Velodyne Lidar, Inc. today announced that the YellowScan Surveyor from YellowScan has utilized Velodyne’s groundbreaking sensor technology to generate precise mapping data for an infrastructure construction project on one of Central Europe’s busiest roadways. YellowScan Surveyor, an unmanned aerial vehicle (UAV) surveying system, improves upon previous time-intensive manual surveying processes by providing a more efficient method for collecting landscape data with increased precision and detail. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190123005054/en/ Ventus-Tech using YellowScan Surveyor, which includes Velodyne Lidar’s Puck™, to generate precise mapping data. (Photo: Business Wire) The project was conducted by Ventus-Tech using YellowScan Surveyor to collect data along a 47-kilometer segment of the M1 highway (E60, E65, E75) in northwestern Hungary. The data, gathered by 88 UAV flights over one month, enabled engine
PMI Among Elite Group of Companies to Score A for Climate Change23.1.2019 15:00 | Tiedote
Philip Morris International Inc. (PMI) (NYSE: PM) has been highlighted as a global leader on corporate climate action by environmental impact nonprofit CDP, achieving a place on the CDP Climate Change A List for the fifth consecutive year. As the only tobacco company to have scored an A, PMI has been recognized for cutting emissions, mitigating climate risks and developing the low-carbon economy, based on its 2018 disclosure to CDP. “Climate change is one of major concerns for humanity, and companies can make a difference. Just like we are leading our industry’s transformation toward a smoke-free future, we are focused on bettering every part of our business and supply chain to become a leader in sustainable business practices,” said André Calantzopoulos, Chief Executive Officer, PMI. The company’s efforts to reduce the environmental footprint of its operations focus on sustainable design in new facilities, energy efficiency in manufacturing processes, greener purchasing of electricity
STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance23.1.2019 14:00 | Tiedote
STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published feeder-free human pluripotent stem cell (hPSC) maintenance medium. The new medium has undergone successful beta testing with several members of the Stem Cell COREdinates group and has completed rigorous in-house validation testing. Designed to promote a more consistent cell culture environment through sustained medium pH and stabilized components including FGF2, mTeSR™ Plus prevents the rapid onset of acidosis. This helps avoid conditions that have been associated with DNA damage, genomic instability, and growth arrest in hPSCs. The stabilization enhancements allow for greater hPSC expansion rates, enhanced culture morphology, and truly versatile feeding schedules including the option to skip weekends. “With the launch of mTeSR™ Plus, STEMCELL is positioned to set new industry standards in the pluripotent stem cell research field,” says Dr. Allen Eaves, President and CEO of STEMCEL
REPLY Study on Artificial Intelligence: Quo vadis, AI?23.1.2019 13:00 | Tiedote
Artificial intelligence enable machines to better understand the surrounding context, giving them the ability to recognise sight, sound and speech. This is made possible by machine learning algorithms. A current study by Reply, conducted with the trend platform SONAR, shows which trends are still relevant in this area. The study highlights some aspects of the future potential of Artificial Intelligence (AI). Complex algorithms, Edge Computing tools that reduce latency periods and AI-specific hardware are yielding many new products and services for mobile computing, the Internet of Things (IoT) and Human-machine Interfaces. There are many different possible scenarios, and three trends play a major role in determining AI’s future as a game changer: AI-driven analytics In the era of digital transformation, decisions are made based on data with the help of predictive analytics. Companies in diverse industries use AI-as-a-service solutions from established providers or start-ups and increas
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme